People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DTx Pharma, Inc. | — | Pharmaceuticals | Series D+ | $113.4M | $2.9B | 2020 |
John Grundy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Grundy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Adams | 1 | 13 |
| Daniel Becker | 1 | 5 |
| MATTHEW HAMMOND | 1 | 5 |
| Jeffrey Friedman | 1 | 4 |
| Tim Scott | 1 | 1 |
| Arthur T Suckow | 1 | 1 |
| John T Grundy | 1 | 1 |
| Jeffrey T Friedman | 1 | 1 |
| Arthur Suckow | 1 | 1 |
| John Rundy | 1 | 1 |
| Niki Upper | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.